Literature DB >> 30155702

A critical analysis of L-asparaginase activity quantification methods-colorimetric methods versus high-performance liquid chromatography.

Agnes Magri1, Matheus F Soler1, André M Lopes1, Eduardo M Cilli2, Patrick S Barber3, Adalberto Pessoa4, Jorge F B Pereira5.   

Abstract

L-asparaginase or ASNase (L-asparagine aminohydrolase, E.C.3.5.1.1) is an enzyme clinically accepted as an antitumor agent to treat acute lymphoblastic leukemia (ALL) and lymphosarcoma through the depletion of L-asparagine (L-Asn) resulting in cytotoxicity to leukemic cells. ASNase is also important in the food industry, preventing acrylamide formation in processed foods. Several quantification techniques have been developed and used for the measurement of the ASNase activity, but standard pharmaceutical quality control methods were hardly reported, and in general, no official quality control guidelines were defined. To overcome this lack of information and to demonstrate the advantages and limitations, this work properly compares the traditional colorimetric methods (Nessler; L-aspartic acid β-hydroxamate (AHA); and indooxine) and the high-performance liquid chromatography (HPLC) method. A comparison of the methods using pure ASNase shows that the colorimetric methods both overestimate (Nessler) and underestimate (AHA and indooxine) the ASNase activity when compared to the values obtained with HPLC, considered the most precise method as this method monitors both substrate consumption and product formation, allowing for overall mass-balance. Correlation and critical analysis of each method relative to the HPLC method were carried out, resulting in a demonstration that it is crucial to select a proper method for the quantification of ASNase activity, allowing bioequivalence studies and individualized monitoring of different ASNase preparations. Graphical abstract ᅟ.

Entities:  

Keywords:  Enzymatic activity; Indooxine; L-asparaginase; L-aspartic acid; L-aspartic acid β-hydroxamate; Nessler

Mesh:

Substances:

Year:  2018        PMID: 30155702     DOI: 10.1007/s00216-018-1326-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  8 in total

Review 1.  Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.

Authors:  Nanxiang Wang; Wenhui Ji; Lan Wang; Wanxia Wu; Wei Zhang; Qiong Wu; Wei Du; Hua Bai; Bo Peng; Bo Ma; Lin Li
Journal:  RSC Med Chem       Date:  2022-01-12

2.  Aliivibrio fischeri L-Asparaginase production by engineered Bacillus subtilis: a potential new biopharmaceutical.

Authors:  Heitor B S Bento; Gabriela B Paiva; Mafalda R Almeida; Claúdia G Silva; Pedro J Carvalho; Ana P M Tavares; Danielle B Pedrolli; Valéria C Santos-Ebinuma
Journal:  Bioprocess Biosyst Eng       Date:  2022-08-16       Impact factor: 3.434

3.  Immobilization and Characterization of L-Asparaginase over Carbon Xerogels.

Authors:  Rita A M Barros; Raquel O Cristóvão; Sónia A C Carabineiro; Márcia C Neves; Mara G Freire; Joaquim L Faria; Valéria C Santos-Ebinuma; Ana P M Tavares; Cláudia G Silva
Journal:  BioTech (Basel)       Date:  2022-04-14

4.  Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center.

Authors:  Daiane Keller Cecconello; Ciliana Rechenmacher; Isabel Werlang; Priscila Pini Zenatti; Jose Andres Yunes; Ana Paula Alegretti; Claudia Lanvers-Kaminsky; Liane Esteves Daudt; Mariana Bohns Michalowski
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

5.  Enhanced Enzyme Reuse through the Bioconjugation of L-Asparaginase and Silica-Based Supported Ionic Liquid-like Phase Materials.

Authors:  João C F Nunes; Mafalda R Almeida; Rui M F Bento; Matheus M Pereira; Valéria C Santos-Ebinuma; Márcia C Neves; Mara G Freire; Ana P M Tavares
Journal:  Molecules       Date:  2022-01-29       Impact factor: 4.411

6.  Development and characterization of a novel l-asparaginase/MWCNT nanobioconjugate.

Authors:  Raquel O Cristóvão; Mafalda R Almeida; Maria A Barros; João C F Nunes; Rui A R Boaventura; José M Loureiro; Joaquim L Faria; Márcia C Neves; Mara G Freire; Valéria C Ebinuma-Santos; Ana P M Tavares; Cláudia G Silva
Journal:  RSC Adv       Date:  2020-08-24       Impact factor: 4.036

7.  Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials.

Authors:  Jasmeet Sidhu; Ashish Narayan Masurekar; Manash Pratim Gogoi; Caroline Fong; Tasos Ioannou; Taha Lodhi; Catriona Parker; Jizhong Liu; Amy A Kirkwood; Anthony V Moorman; Kiranmoy Das; Nicholas J Goulden; Ajay Vora; Vaskar Saha; Shekhar Krishnan
Journal:  Br J Haematol       Date:  2022-03-29       Impact factor: 8.615

8.  Superior operational stability of immobilized L-asparaginase over surface-modified carbon nanotubes.

Authors:  Mafalda R Almeida; Raquel O Cristóvão; Maria A Barros; João C F Nunes; Rui A R Boaventura; José M Loureiro; Joaquim L Faria; Márcia C Neves; Mara G Freire; Valéria C Santos-Ebinuma; Ana P M Tavares; Cláudia G Silva
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.